U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. FDA’s Proposal for a Unified Human Foods Program and New Model for the Office of Regulatory Affairs
  1. FDA Organization

FDA’s Proposal for a Unified Human Foods Program and New Model for the Office of Regulatory Affairs

Unified FDA Human Foods Program

The FDA is focused on transforming the agency to be more efficient, nimble and ready for the future with the ever-changing and complex industries we regulate, including the emergence of new food technologies, the impacts of globalization, climate change and other factors that require the FDA to quickly adapt to an evolving world. 

In January 2023, the FDA announced it would develop a proposal for a unified Human Foods Program (HFP) and new Office of Regulatory Affairs (ORA) model after carefully reviewing the findings and recommendations of a Reagan-Udall Foundation evaluation, an internal review of the agency’s infant formula response and feedback from external and internal stakeholders, such as during listening sessions with FDA employees. 

If approved, the proposed changes will allow the agency to:

  • Fully realize the preventive vision laid out in the FDA Food Safety Modernization Act. 
  • Elevate the importance of nutrition to help reduce diet-related diseases.
  • Strengthen state partnerships and embrace innovative food and agricultural technologies that will position the agency to more effectively regulate and uphold safety of the nation’s food supply. 

The FDA is proposing changes that will impact other commodities we regulate, such as medical products and cosmetics, by creating an enterprise-wide structure that will enhance collaboration between ORA investigators and subject matter experts throughout the entire agency. The proposal includes additional improvements to modernize and strengthen the entire agency to work more cohesively and collaboratively together to accomplish its public health mission.  

The FDA completed its proposed reorganization package in December 2023. It is currently undergoing a formal external review process required for all federal reorganizations. The FDA is hopeful implementation will occur sometime in calendar year 2024.


Proposed Organizational Structures


Back to Top